William A. Wegener

7.5k citations
101 papers · 6k · 2 hit papers · h-index 38

Impact in

Papers in

William A. Wegener

101 papers receiving 5.8k citations

William A. Wegener's Hit Papers

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial 2021 · 322 citations
3220+2+4Years since publication200400600

Peers

William A. Wegener
Comparison fields: 5 of 92
  • Radiology, Nuclear Medicine and Imaging 1.5k
  • Cancer Research 751
  • Pathology and Forensic Medicine 842
  • Oncology 923
  • Rheumatology 505
Replace Sandra Silberman with:
Sandra Silberman United States
K. Höffken Germany
Christoph Renner Switzerland
Atif Zaheer United States
Ate G.J. van der Zee Netherlands
Samuel A. Jacobs United States
Jacob P. Laubach United States
Janet F. Eary United States
Eric L. Sievers United States
Sayuri Ohno-Jones United States
William A. Wegener relative to Sandra Silberman United States Sandra Silberman's profile →
Citations per field
00.5×2×3.5×
Sandra Silberman · 1×
Citations per year

Countries citing papers authored by William A. Wegener

Since Specialization
Citations

This map shows the geographic impact of William A. Wegener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Wegener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Wegener more than expected).

Fields of papers citing papers by William A. Wegener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Wegener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Wegener. The network helps show where William A. Wegener may publish in the future.

Co-authors

The 25 scholars most cited alongside William A. Wegener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William A. Wegener Line = papers co-authored together William A. Wegener links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
Hit paper breakdown →
2019704
2 2017346
3
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
Hit paper breakdown →
2021322
4 2015284
5 2006256
6 2017211
7 2006210
8 2003209
9 2004199
10 2008177
11 2017171
12 2005143
13 2009141
14 2017140
15 2020125
16 2006123
17 2013111
18 2005110
19 2013101
20 201096

About William A. Wegener

William A. Wegener is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Fluid Flow and Transfer Processes, Oncology and Hematology, having authored 101 papers that have together received 6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Acute Lymphoblastic Leukemia research (9 papers), Diffusion Coefficients in Liquids (8 papers), Rheology and Fluid Dynamics Studies (7 papers), Platelet Disorders and Treatments (6 papers), Systemic Lupus Erythematosus Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.5k citations), Cancer Research (751 citations), Pathology and Forensic Medicine (842 citations), Oncology (923 citations) and Rheumatology (505 citations). William A. Wegener has collaborated with scholars based in United States, France and Germany. Frequent co-authors include David M. Goldenberg, Robert M. Sharkey, Linda T. Vahdat, Gerd Rüdiger Burmester, Heather Bethea Horne, Aditya Bardia, Morton Coleman, John Paul Leonard, Ingrid A. Mayer and Nick Teoh. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Cancer and Biopolymers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact